Apr 9Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer Findings from scientists at St. Jude Children’s Research Hospital and The University of Tennessee Health Science Center suggest T-cell...
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies